Global Extended Oral Antibiotics Supply, Demand and Key Producers, 2026-2032
The global Extended Oral Antibiotics market size is expected to reach $ 4382 million by 2032, rising at a market growth of 5.4% CAGR during the forecast period (2026-2032).
Extended Oral Antibiotics refer to antibiotic drug products administered via the oral route that are formulated to achieve prolonged therapeutic plasma concentrations through modified-release drug delivery technologies or standard oral antibiotic formulations prescribed for extended treatment durations for complicated or chronic bacterial infections. In 2025,global wide neck baby bottles production reached approximately 777,134 K unit, with an average global market price of around USD 3,800 per K unit. A factory gross profit of USD 760 per K unit with 20% gross margin. A single line full machine capacity production is around 150 K unit per line per year. The upstream is dependent on active pharmaceutical ingredients, formulations components and intermediates. The downstream demand is concentrated in hospitals, specialty clinics and pharmacy. Extended oral antibiotic use for dental infections is generally reserved for severe or spreading condition such as tooth abscess. it's control bacterial spread. China market is driven by large antibiotic production capacity and expanding healthcare coverage.
This report studies the global Extended Oral Antibiotics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Extended Oral Antibiotics and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Extended Oral Antibiotics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Extended Oral Antibiotics total production and demand, 2021-2032, (K Units)
Global Extended Oral Antibiotics total production value, 2021-2032, (USD Million)
Global Extended Oral Antibiotics production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Extended Oral Antibiotics consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Extended Oral Antibiotics domestic production, consumption, key domestic manufacturers and share
Global Extended Oral Antibiotics production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Extended Oral Antibiotics production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Extended Oral Antibiotics production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Extended Oral Antibiotics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., GSK plc., Merck & Co., Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries, Viatris Inc., Aurobindo Pharma Ltd, Sun Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Extended Oral Antibiotics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Extended Oral Antibiotics Market, By Region:
1. How big is the global Extended Oral Antibiotics market?
2. What is the demand of the global Extended Oral Antibiotics market?
3. What is the year over year growth of the global Extended Oral Antibiotics market?
4. What is the production and production value of the global Extended Oral Antibiotics market?
5. Who are the key producers in the global Extended Oral Antibiotics market?
6. What are the growth factors driving the market demand?
Extended Oral Antibiotics refer to antibiotic drug products administered via the oral route that are formulated to achieve prolonged therapeutic plasma concentrations through modified-release drug delivery technologies or standard oral antibiotic formulations prescribed for extended treatment durations for complicated or chronic bacterial infections. In 2025,global wide neck baby bottles production reached approximately 777,134 K unit, with an average global market price of around USD 3,800 per K unit. A factory gross profit of USD 760 per K unit with 20% gross margin. A single line full machine capacity production is around 150 K unit per line per year. The upstream is dependent on active pharmaceutical ingredients, formulations components and intermediates. The downstream demand is concentrated in hospitals, specialty clinics and pharmacy. Extended oral antibiotic use for dental infections is generally reserved for severe or spreading condition such as tooth abscess. it's control bacterial spread. China market is driven by large antibiotic production capacity and expanding healthcare coverage.
This report studies the global Extended Oral Antibiotics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Extended Oral Antibiotics and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Extended Oral Antibiotics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Extended Oral Antibiotics total production and demand, 2021-2032, (K Units)
Global Extended Oral Antibiotics total production value, 2021-2032, (USD Million)
Global Extended Oral Antibiotics production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Extended Oral Antibiotics consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Extended Oral Antibiotics domestic production, consumption, key domestic manufacturers and share
Global Extended Oral Antibiotics production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Extended Oral Antibiotics production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Extended Oral Antibiotics production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Extended Oral Antibiotics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., GSK plc., Merck & Co., Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries, Viatris Inc., Aurobindo Pharma Ltd, Sun Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Extended Oral Antibiotics market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Extended Oral Antibiotics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Extended Release Oral Antibiotics
- Oral Penicillin Derivatives
- Oral Cephalosporins
- Oral Macrolides
- Others
- Narrow Spectrum Antibiotics
- Broad Spectrum Antibiotics
- Short Extended Course (7-10 Days)
- Standard Extended Course (10-14 Days)
- Prolonged Course (14-28 Days)
- Long Term Suppression (>28 Days to Months)
- Others
- Hospitals
- Clinics
- Pharmacy
- Others
- Pfizer Inc.
- GSK plc.
- Merck & Co., Inc.
- Novartis AG
- Sanofi S.A.
- Teva Pharmaceutical Industries
- Viatris Inc.
- Aurobindo Pharma Ltd
- Sun Pharmaceutical Industries Ltd
- Dr. Reddy's Laboratories Ltd
- Cipla Ltd
- Lupin Ltd
- Zhejiang Hisun Pharmaceutical Co., Ltd
- Takeda Pharmaceutical Company Ltd
- Daiichi Sankyo Company Ltd
- Meiji Seika Pharma Co., Ltd
- Boryung Co., Ltd
- Orchid Pharma Ltd
- CSPC Pharmaceutical Group Ltd
- Aspen Pharmacare Holdings Ltd
- North China Pharmaceutical Group Corp
- Shandong Lukang Pharmaceutical Co., Ltd
- Zentiva
- RedHill Biopharma Ltd
- TaiGen Biotechnology Co., Ltd
- Taiwan Biotech Co., Ltd
- Centrient Pharmaceuticals
- Nabriva Therapeutics plc
- Melinta Therapeutics Inc.
- Lonza Group
1. How big is the global Extended Oral Antibiotics market?
2. What is the demand of the global Extended Oral Antibiotics market?
3. What is the year over year growth of the global Extended Oral Antibiotics market?
4. What is the production and production value of the global Extended Oral Antibiotics market?
5. Who are the key producers in the global Extended Oral Antibiotics market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Extended Oral Antibiotics Introduction
1.2 World Extended Oral Antibiotics Supply & Forecast
1.2.1 World Extended Oral Antibiotics Production Value (2021 & 2025 & 2032)
1.2.2 World Extended Oral Antibiotics Production (2021-2032)
1.2.3 World Extended Oral Antibiotics Pricing Trends (2021-2032)
1.3 World Extended Oral Antibiotics Production by Region (Based on Production Site)
1.3.1 World Extended Oral Antibiotics Production Value by Region (2021-2032)
1.3.2 World Extended Oral Antibiotics Production by Region (2021-2032)
1.3.3 World Extended Oral Antibiotics Average Price by Region (2021-2032)
1.3.4 North America Extended Oral Antibiotics Production (2021-2032)
1.3.5 Europe Extended Oral Antibiotics Production (2021-2032)
1.3.6 China Extended Oral Antibiotics Production (2021-2032)
1.3.7 Japan Extended Oral Antibiotics Production (2021-2032)
1.3.8 India Extended Oral Antibiotics Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Extended Oral Antibiotics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Extended Oral Antibiotics Major Market Trends
2 DEMAND SUMMARY
2.1 World Extended Oral Antibiotics Demand (2021-2032)
2.2 World Extended Oral Antibiotics Consumption by Region
2.2.1 World Extended Oral Antibiotics Consumption by Region (2021-2026)
2.2.2 World Extended Oral Antibiotics Consumption Forecast by Region (2027-2032)
2.3 United States Extended Oral Antibiotics Consumption (2021-2032)
2.4 China Extended Oral Antibiotics Consumption (2021-2032)
2.5 Europe Extended Oral Antibiotics Consumption (2021-2032)
2.6 Japan Extended Oral Antibiotics Consumption (2021-2032)
2.7 South Korea Extended Oral Antibiotics Consumption (2021-2032)
2.8 ASEAN Extended Oral Antibiotics Consumption (2021-2032)
2.9 India Extended Oral Antibiotics Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Extended Oral Antibiotics Production Value by Manufacturer (2021-2026)
3.2 World Extended Oral Antibiotics Production by Manufacturer (2021-2026)
3.3 World Extended Oral Antibiotics Average Price by Manufacturer (2021-2026)
3.4 Extended Oral Antibiotics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Extended Oral Antibiotics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Extended Oral Antibiotics in 2025
3.5.3 Global Concentration Ratios (CR8) for Extended Oral Antibiotics in 2025
3.6 Extended Oral Antibiotics Market: Overall Company Footprint Analysis
3.6.1 Extended Oral Antibiotics Market: Region Footprint
3.6.2 Extended Oral Antibiotics Market: Company Product Type Footprint
3.6.3 Extended Oral Antibiotics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Extended Oral Antibiotics Production Value Comparison
4.1.1 United States VS China: Extended Oral Antibiotics Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Extended Oral Antibiotics Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Extended Oral Antibiotics Production Comparison
4.2.1 United States VS China: Extended Oral Antibiotics Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Extended Oral Antibiotics Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Extended Oral Antibiotics Consumption Comparison
4.3.1 United States VS China: Extended Oral Antibiotics Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Extended Oral Antibiotics Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Extended Oral Antibiotics Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Extended Oral Antibiotics Production Value (2021-2026)
4.4.3 United States Based Manufacturers Extended Oral Antibiotics Production (2021-2026)
4.5 China Based Extended Oral Antibiotics Manufacturers and Market Share
4.5.1 China Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Extended Oral Antibiotics Production Value (2021-2026)
4.5.3 China Based Manufacturers Extended Oral Antibiotics Production (2021-2026)
4.6 Rest of World Based Extended Oral Antibiotics Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Extended Oral Antibiotics Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Extended Oral Antibiotics Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Extended Oral Antibiotics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Extended Release Oral Antibiotics
5.2.2 Oral Penicillin Derivatives
5.2.3 Oral Cephalosporins
5.2.4 Oral Macrolides
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Extended Oral Antibiotics Production by Type (2021-2032)
5.3.2 World Extended Oral Antibiotics Production Value by Type (2021-2032)
5.3.3 World Extended Oral Antibiotics Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ANTIBIOTIC SPECTRUM
6.1 World Extended Oral Antibiotics Market Size Overview by Antibiotic Spectrum: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Antibiotic Spectrum
6.2.1 Narrow Spectrum Antibiotics
6.2.2 Broad Spectrum Antibiotics
6.3 Market Segment by Antibiotic Spectrum
6.3.1 World Extended Oral Antibiotics Production by Antibiotic Spectrum (2021-2032)
6.3.2 World Extended Oral Antibiotics Production Value by Antibiotic Spectrum (2021-2032)
6.3.3 World Extended Oral Antibiotics Average Price by Antibiotic Spectrum (2021-2032)
7 MARKET ANALYSIS BY TREATMENT DURATION
7.1 World Extended Oral Antibiotics Market Size Overview by Treatment Duration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Treatment Duration
7.2.1 Short Extended Course (7-10 Days)
7.2.2 Standard Extended Course (10-14 Days)
7.2.3 Prolonged Course (14-28 Days)
7.2.4 Long Term Suppression (>28 Days to Months)
7.2.5 Others
7.3 Market Segment by Treatment Duration
7.3.1 World Extended Oral Antibiotics Production by Treatment Duration (2021-2032)
7.3.2 World Extended Oral Antibiotics Production Value by Treatment Duration (2021-2032)
7.3.3 World Extended Oral Antibiotics Average Price by Treatment Duration (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Extended Oral Antibiotics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Pharmacy
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Extended Oral Antibiotics Production by Application (2021-2032)
8.3.2 World Extended Oral Antibiotics Production Value by Application (2021-2032)
8.3.3 World Extended Oral Antibiotics Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Details
9.1.2 Pfizer Inc. Major Business
9.1.3 Pfizer Inc. Extended Oral Antibiotics Product and Services
9.1.4 Pfizer Inc. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Inc. Recent Developments/Updates
9.1.6 Pfizer Inc. Competitive Strengths & Weaknesses
9.2 GSK plc.
9.2.1 GSK plc. Details
9.2.2 GSK plc. Major Business
9.2.3 GSK plc. Extended Oral Antibiotics Product and Services
9.2.4 GSK plc. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK plc. Recent Developments/Updates
9.2.6 GSK plc. Competitive Strengths & Weaknesses
9.3 Merck & Co., Inc.
9.3.1 Merck & Co., Inc. Details
9.3.2 Merck & Co., Inc. Major Business
9.3.3 Merck & Co., Inc. Extended Oral Antibiotics Product and Services
9.3.4 Merck & Co., Inc. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Merck & Co., Inc. Recent Developments/Updates
9.3.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
9.4 Novartis AG
9.4.1 Novartis AG Details
9.4.2 Novartis AG Major Business
9.4.3 Novartis AG Extended Oral Antibiotics Product and Services
9.4.4 Novartis AG Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Novartis AG Recent Developments/Updates
9.4.6 Novartis AG Competitive Strengths & Weaknesses
9.5 Sanofi S.A.
9.5.1 Sanofi S.A. Details
9.5.2 Sanofi S.A. Major Business
9.5.3 Sanofi S.A. Extended Oral Antibiotics Product and Services
9.5.4 Sanofi S.A. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Sanofi S.A. Recent Developments/Updates
9.5.6 Sanofi S.A. Competitive Strengths & Weaknesses
9.6 Teva Pharmaceutical Industries
9.6.1 Teva Pharmaceutical Industries Details
9.6.2 Teva Pharmaceutical Industries Major Business
9.6.3 Teva Pharmaceutical Industries Extended Oral Antibiotics Product and Services
9.6.4 Teva Pharmaceutical Industries Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.6.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.7 Viatris Inc.
9.7.1 Viatris Inc. Details
9.7.2 Viatris Inc. Major Business
9.7.3 Viatris Inc. Extended Oral Antibiotics Product and Services
9.7.4 Viatris Inc. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Viatris Inc. Recent Developments/Updates
9.7.6 Viatris Inc. Competitive Strengths & Weaknesses
9.8 Aurobindo Pharma Ltd
9.8.1 Aurobindo Pharma Ltd Details
9.8.2 Aurobindo Pharma Ltd Major Business
9.8.3 Aurobindo Pharma Ltd Extended Oral Antibiotics Product and Services
9.8.4 Aurobindo Pharma Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Aurobindo Pharma Ltd Recent Developments/Updates
9.8.6 Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
9.9 Sun Pharmaceutical Industries Ltd
9.9.1 Sun Pharmaceutical Industries Ltd Details
9.9.2 Sun Pharmaceutical Industries Ltd Major Business
9.9.3 Sun Pharmaceutical Industries Ltd Extended Oral Antibiotics Product and Services
9.9.4 Sun Pharmaceutical Industries Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
9.9.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
9.10 Dr. Reddy's Laboratories Ltd
9.10.1 Dr. Reddy's Laboratories Ltd Details
9.10.2 Dr. Reddy's Laboratories Ltd Major Business
9.10.3 Dr. Reddy's Laboratories Ltd Extended Oral Antibiotics Product and Services
9.10.4 Dr. Reddy's Laboratories Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Dr. Reddy's Laboratories Ltd Recent Developments/Updates
9.10.6 Dr. Reddy's Laboratories Ltd Competitive Strengths & Weaknesses
9.11 Cipla Ltd
9.11.1 Cipla Ltd Details
9.11.2 Cipla Ltd Major Business
9.11.3 Cipla Ltd Extended Oral Antibiotics Product and Services
9.11.4 Cipla Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Cipla Ltd Recent Developments/Updates
9.11.6 Cipla Ltd Competitive Strengths & Weaknesses
9.12 Lupin Ltd
9.12.1 Lupin Ltd Details
9.12.2 Lupin Ltd Major Business
9.12.3 Lupin Ltd Extended Oral Antibiotics Product and Services
9.12.4 Lupin Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Lupin Ltd Recent Developments/Updates
9.12.6 Lupin Ltd Competitive Strengths & Weaknesses
9.13 Zhejiang Hisun Pharmaceutical Co., Ltd
9.13.1 Zhejiang Hisun Pharmaceutical Co., Ltd Details
9.13.2 Zhejiang Hisun Pharmaceutical Co., Ltd Major Business
9.13.3 Zhejiang Hisun Pharmaceutical Co., Ltd Extended Oral Antibiotics Product and Services
9.13.4 Zhejiang Hisun Pharmaceutical Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
9.13.6 Zhejiang Hisun Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
9.14 Takeda Pharmaceutical Company Ltd
9.14.1 Takeda Pharmaceutical Company Ltd Details
9.14.2 Takeda Pharmaceutical Company Ltd Major Business
9.14.3 Takeda Pharmaceutical Company Ltd Extended Oral Antibiotics Product and Services
9.14.4 Takeda Pharmaceutical Company Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Takeda Pharmaceutical Company Ltd Recent Developments/Updates
9.14.6 Takeda Pharmaceutical Company Ltd Competitive Strengths & Weaknesses
9.15 Daiichi Sankyo Company Ltd
9.15.1 Daiichi Sankyo Company Ltd Details
9.15.2 Daiichi Sankyo Company Ltd Major Business
9.15.3 Daiichi Sankyo Company Ltd Extended Oral Antibiotics Product and Services
9.15.4 Daiichi Sankyo Company Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Daiichi Sankyo Company Ltd Recent Developments/Updates
9.15.6 Daiichi Sankyo Company Ltd Competitive Strengths & Weaknesses
9.16 Meiji Seika Pharma Co., Ltd
9.16.1 Meiji Seika Pharma Co., Ltd Details
9.16.2 Meiji Seika Pharma Co., Ltd Major Business
9.16.3 Meiji Seika Pharma Co., Ltd Extended Oral Antibiotics Product and Services
9.16.4 Meiji Seika Pharma Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Meiji Seika Pharma Co., Ltd Recent Developments/Updates
9.16.6 Meiji Seika Pharma Co., Ltd Competitive Strengths & Weaknesses
9.17 Boryung Co., Ltd
9.17.1 Boryung Co., Ltd Details
9.17.2 Boryung Co., Ltd Major Business
9.17.3 Boryung Co., Ltd Extended Oral Antibiotics Product and Services
9.17.4 Boryung Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Boryung Co., Ltd Recent Developments/Updates
9.17.6 Boryung Co., Ltd Competitive Strengths & Weaknesses
9.18 Orchid Pharma Ltd
9.18.1 Orchid Pharma Ltd Details
9.18.2 Orchid Pharma Ltd Major Business
9.18.3 Orchid Pharma Ltd Extended Oral Antibiotics Product and Services
9.18.4 Orchid Pharma Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Orchid Pharma Ltd Recent Developments/Updates
9.18.6 Orchid Pharma Ltd Competitive Strengths & Weaknesses
9.19 CSPC Pharmaceutical Group Ltd
9.19.1 CSPC Pharmaceutical Group Ltd Details
9.19.2 CSPC Pharmaceutical Group Ltd Major Business
9.19.3 CSPC Pharmaceutical Group Ltd Extended Oral Antibiotics Product and Services
9.19.4 CSPC Pharmaceutical Group Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 CSPC Pharmaceutical Group Ltd Recent Developments/Updates
9.19.6 CSPC Pharmaceutical Group Ltd Competitive Strengths & Weaknesses
9.20 Aspen Pharmacare Holdings Ltd
9.20.1 Aspen Pharmacare Holdings Ltd Details
9.20.2 Aspen Pharmacare Holdings Ltd Major Business
9.20.3 Aspen Pharmacare Holdings Ltd Extended Oral Antibiotics Product and Services
9.20.4 Aspen Pharmacare Holdings Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Aspen Pharmacare Holdings Ltd Recent Developments/Updates
9.20.6 Aspen Pharmacare Holdings Ltd Competitive Strengths & Weaknesses
9.21 North China Pharmaceutical Group Corp
9.21.1 North China Pharmaceutical Group Corp Details
9.21.2 North China Pharmaceutical Group Corp Major Business
9.21.3 North China Pharmaceutical Group Corp Extended Oral Antibiotics Product and Services
9.21.4 North China Pharmaceutical Group Corp Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 North China Pharmaceutical Group Corp Recent Developments/Updates
9.21.6 North China Pharmaceutical Group Corp Competitive Strengths & Weaknesses
9.22 Shandong Lukang Pharmaceutical Co., Ltd
9.22.1 Shandong Lukang Pharmaceutical Co., Ltd Details
9.22.2 Shandong Lukang Pharmaceutical Co., Ltd Major Business
9.22.3 Shandong Lukang Pharmaceutical Co., Ltd Extended Oral Antibiotics Product and Services
9.22.4 Shandong Lukang Pharmaceutical Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Shandong Lukang Pharmaceutical Co., Ltd Recent Developments/Updates
9.22.6 Shandong Lukang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
9.23 Zentiva
9.23.1 Zentiva Details
9.23.2 Zentiva Major Business
9.23.3 Zentiva Extended Oral Antibiotics Product and Services
9.23.4 Zentiva Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Zentiva Recent Developments/Updates
9.23.6 Zentiva Competitive Strengths & Weaknesses
9.24 RedHill Biopharma Ltd
9.24.1 RedHill Biopharma Ltd Details
9.24.2 RedHill Biopharma Ltd Major Business
9.24.3 RedHill Biopharma Ltd Extended Oral Antibiotics Product and Services
9.24.4 RedHill Biopharma Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 RedHill Biopharma Ltd Recent Developments/Updates
9.24.6 RedHill Biopharma Ltd Competitive Strengths & Weaknesses
9.25 TaiGen Biotechnology Co., Ltd
9.25.1 TaiGen Biotechnology Co., Ltd Details
9.25.2 TaiGen Biotechnology Co., Ltd Major Business
9.25.3 TaiGen Biotechnology Co., Ltd Extended Oral Antibiotics Product and Services
9.25.4 TaiGen Biotechnology Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 TaiGen Biotechnology Co., Ltd Recent Developments/Updates
9.25.6 TaiGen Biotechnology Co., Ltd Competitive Strengths & Weaknesses
9.26 Taiwan Biotech Co., Ltd
9.26.1 Taiwan Biotech Co., Ltd Details
9.26.2 Taiwan Biotech Co., Ltd Major Business
9.26.3 Taiwan Biotech Co., Ltd Extended Oral Antibiotics Product and Services
9.26.4 Taiwan Biotech Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Taiwan Biotech Co., Ltd Recent Developments/Updates
9.26.6 Taiwan Biotech Co., Ltd Competitive Strengths & Weaknesses
9.27 Centrient Pharmaceuticals
9.27.1 Centrient Pharmaceuticals Details
9.27.2 Centrient Pharmaceuticals Major Business
9.27.3 Centrient Pharmaceuticals Extended Oral Antibiotics Product and Services
9.27.4 Centrient Pharmaceuticals Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Centrient Pharmaceuticals Recent Developments/Updates
9.27.6 Centrient Pharmaceuticals Competitive Strengths & Weaknesses
9.28 Nabriva Therapeutics plc
9.28.1 Nabriva Therapeutics plc Details
9.28.2 Nabriva Therapeutics plc Major Business
9.28.3 Nabriva Therapeutics plc Extended Oral Antibiotics Product and Services
9.28.4 Nabriva Therapeutics plc Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.28.5 Nabriva Therapeutics plc Recent Developments/Updates
9.28.6 Nabriva Therapeutics plc Competitive Strengths & Weaknesses
9.29 Melinta Therapeutics Inc.
9.29.1 Melinta Therapeutics Inc. Details
9.29.2 Melinta Therapeutics Inc. Major Business
9.29.3 Melinta Therapeutics Inc. Extended Oral Antibiotics Product and Services
9.29.4 Melinta Therapeutics Inc. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.29.5 Melinta Therapeutics Inc. Recent Developments/Updates
9.29.6 Melinta Therapeutics Inc. Competitive Strengths & Weaknesses
9.30 Lonza Group
9.30.1 Lonza Group Details
9.30.2 Lonza Group Major Business
9.30.3 Lonza Group Extended Oral Antibiotics Product and Services
9.30.4 Lonza Group Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.30.5 Lonza Group Recent Developments/Updates
9.30.6 Lonza Group Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Extended Oral Antibiotics Industry Chain
10.2 Extended Oral Antibiotics Upstream Analysis
10.2.1 Extended Oral Antibiotics Core Raw Materials
10.2.2 Main Manufacturers of Extended Oral Antibiotics Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Extended Oral Antibiotics Production Mode
10.6 Extended Oral Antibiotics Procurement Model
10.7 Extended Oral Antibiotics Industry Sales Model and Sales Channels
10.7.1 Extended Oral Antibiotics Sales Model
10.7.2 Extended Oral Antibiotics Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Extended Oral Antibiotics Introduction
1.2 World Extended Oral Antibiotics Supply & Forecast
1.2.1 World Extended Oral Antibiotics Production Value (2021 & 2025 & 2032)
1.2.2 World Extended Oral Antibiotics Production (2021-2032)
1.2.3 World Extended Oral Antibiotics Pricing Trends (2021-2032)
1.3 World Extended Oral Antibiotics Production by Region (Based on Production Site)
1.3.1 World Extended Oral Antibiotics Production Value by Region (2021-2032)
1.3.2 World Extended Oral Antibiotics Production by Region (2021-2032)
1.3.3 World Extended Oral Antibiotics Average Price by Region (2021-2032)
1.3.4 North America Extended Oral Antibiotics Production (2021-2032)
1.3.5 Europe Extended Oral Antibiotics Production (2021-2032)
1.3.6 China Extended Oral Antibiotics Production (2021-2032)
1.3.7 Japan Extended Oral Antibiotics Production (2021-2032)
1.3.8 India Extended Oral Antibiotics Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Extended Oral Antibiotics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Extended Oral Antibiotics Major Market Trends
2 DEMAND SUMMARY
2.1 World Extended Oral Antibiotics Demand (2021-2032)
2.2 World Extended Oral Antibiotics Consumption by Region
2.2.1 World Extended Oral Antibiotics Consumption by Region (2021-2026)
2.2.2 World Extended Oral Antibiotics Consumption Forecast by Region (2027-2032)
2.3 United States Extended Oral Antibiotics Consumption (2021-2032)
2.4 China Extended Oral Antibiotics Consumption (2021-2032)
2.5 Europe Extended Oral Antibiotics Consumption (2021-2032)
2.6 Japan Extended Oral Antibiotics Consumption (2021-2032)
2.7 South Korea Extended Oral Antibiotics Consumption (2021-2032)
2.8 ASEAN Extended Oral Antibiotics Consumption (2021-2032)
2.9 India Extended Oral Antibiotics Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Extended Oral Antibiotics Production Value by Manufacturer (2021-2026)
3.2 World Extended Oral Antibiotics Production by Manufacturer (2021-2026)
3.3 World Extended Oral Antibiotics Average Price by Manufacturer (2021-2026)
3.4 Extended Oral Antibiotics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Extended Oral Antibiotics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Extended Oral Antibiotics in 2025
3.5.3 Global Concentration Ratios (CR8) for Extended Oral Antibiotics in 2025
3.6 Extended Oral Antibiotics Market: Overall Company Footprint Analysis
3.6.1 Extended Oral Antibiotics Market: Region Footprint
3.6.2 Extended Oral Antibiotics Market: Company Product Type Footprint
3.6.3 Extended Oral Antibiotics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Extended Oral Antibiotics Production Value Comparison
4.1.1 United States VS China: Extended Oral Antibiotics Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Extended Oral Antibiotics Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Extended Oral Antibiotics Production Comparison
4.2.1 United States VS China: Extended Oral Antibiotics Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Extended Oral Antibiotics Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Extended Oral Antibiotics Consumption Comparison
4.3.1 United States VS China: Extended Oral Antibiotics Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Extended Oral Antibiotics Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Extended Oral Antibiotics Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Extended Oral Antibiotics Production Value (2021-2026)
4.4.3 United States Based Manufacturers Extended Oral Antibiotics Production (2021-2026)
4.5 China Based Extended Oral Antibiotics Manufacturers and Market Share
4.5.1 China Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Extended Oral Antibiotics Production Value (2021-2026)
4.5.3 China Based Manufacturers Extended Oral Antibiotics Production (2021-2026)
4.6 Rest of World Based Extended Oral Antibiotics Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Extended Oral Antibiotics Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Extended Oral Antibiotics Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Extended Oral Antibiotics Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Extended Release Oral Antibiotics
5.2.2 Oral Penicillin Derivatives
5.2.3 Oral Cephalosporins
5.2.4 Oral Macrolides
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Extended Oral Antibiotics Production by Type (2021-2032)
5.3.2 World Extended Oral Antibiotics Production Value by Type (2021-2032)
5.3.3 World Extended Oral Antibiotics Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ANTIBIOTIC SPECTRUM
6.1 World Extended Oral Antibiotics Market Size Overview by Antibiotic Spectrum: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Antibiotic Spectrum
6.2.1 Narrow Spectrum Antibiotics
6.2.2 Broad Spectrum Antibiotics
6.3 Market Segment by Antibiotic Spectrum
6.3.1 World Extended Oral Antibiotics Production by Antibiotic Spectrum (2021-2032)
6.3.2 World Extended Oral Antibiotics Production Value by Antibiotic Spectrum (2021-2032)
6.3.3 World Extended Oral Antibiotics Average Price by Antibiotic Spectrum (2021-2032)
7 MARKET ANALYSIS BY TREATMENT DURATION
7.1 World Extended Oral Antibiotics Market Size Overview by Treatment Duration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Treatment Duration
7.2.1 Short Extended Course (7-10 Days)
7.2.2 Standard Extended Course (10-14 Days)
7.2.3 Prolonged Course (14-28 Days)
7.2.4 Long Term Suppression (>28 Days to Months)
7.2.5 Others
7.3 Market Segment by Treatment Duration
7.3.1 World Extended Oral Antibiotics Production by Treatment Duration (2021-2032)
7.3.2 World Extended Oral Antibiotics Production Value by Treatment Duration (2021-2032)
7.3.3 World Extended Oral Antibiotics Average Price by Treatment Duration (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Extended Oral Antibiotics Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospitals
8.2.2 Clinics
8.2.3 Pharmacy
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Extended Oral Antibiotics Production by Application (2021-2032)
8.3.2 World Extended Oral Antibiotics Production Value by Application (2021-2032)
8.3.3 World Extended Oral Antibiotics Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer Inc.
9.1.1 Pfizer Inc. Details
9.1.2 Pfizer Inc. Major Business
9.1.3 Pfizer Inc. Extended Oral Antibiotics Product and Services
9.1.4 Pfizer Inc. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Inc. Recent Developments/Updates
9.1.6 Pfizer Inc. Competitive Strengths & Weaknesses
9.2 GSK plc.
9.2.1 GSK plc. Details
9.2.2 GSK plc. Major Business
9.2.3 GSK plc. Extended Oral Antibiotics Product and Services
9.2.4 GSK plc. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 GSK plc. Recent Developments/Updates
9.2.6 GSK plc. Competitive Strengths & Weaknesses
9.3 Merck & Co., Inc.
9.3.1 Merck & Co., Inc. Details
9.3.2 Merck & Co., Inc. Major Business
9.3.3 Merck & Co., Inc. Extended Oral Antibiotics Product and Services
9.3.4 Merck & Co., Inc. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Merck & Co., Inc. Recent Developments/Updates
9.3.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
9.4 Novartis AG
9.4.1 Novartis AG Details
9.4.2 Novartis AG Major Business
9.4.3 Novartis AG Extended Oral Antibiotics Product and Services
9.4.4 Novartis AG Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Novartis AG Recent Developments/Updates
9.4.6 Novartis AG Competitive Strengths & Weaknesses
9.5 Sanofi S.A.
9.5.1 Sanofi S.A. Details
9.5.2 Sanofi S.A. Major Business
9.5.3 Sanofi S.A. Extended Oral Antibiotics Product and Services
9.5.4 Sanofi S.A. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Sanofi S.A. Recent Developments/Updates
9.5.6 Sanofi S.A. Competitive Strengths & Weaknesses
9.6 Teva Pharmaceutical Industries
9.6.1 Teva Pharmaceutical Industries Details
9.6.2 Teva Pharmaceutical Industries Major Business
9.6.3 Teva Pharmaceutical Industries Extended Oral Antibiotics Product and Services
9.6.4 Teva Pharmaceutical Industries Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.6.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.7 Viatris Inc.
9.7.1 Viatris Inc. Details
9.7.2 Viatris Inc. Major Business
9.7.3 Viatris Inc. Extended Oral Antibiotics Product and Services
9.7.4 Viatris Inc. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Viatris Inc. Recent Developments/Updates
9.7.6 Viatris Inc. Competitive Strengths & Weaknesses
9.8 Aurobindo Pharma Ltd
9.8.1 Aurobindo Pharma Ltd Details
9.8.2 Aurobindo Pharma Ltd Major Business
9.8.3 Aurobindo Pharma Ltd Extended Oral Antibiotics Product and Services
9.8.4 Aurobindo Pharma Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Aurobindo Pharma Ltd Recent Developments/Updates
9.8.6 Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
9.9 Sun Pharmaceutical Industries Ltd
9.9.1 Sun Pharmaceutical Industries Ltd Details
9.9.2 Sun Pharmaceutical Industries Ltd Major Business
9.9.3 Sun Pharmaceutical Industries Ltd Extended Oral Antibiotics Product and Services
9.9.4 Sun Pharmaceutical Industries Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
9.9.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
9.10 Dr. Reddy's Laboratories Ltd
9.10.1 Dr. Reddy's Laboratories Ltd Details
9.10.2 Dr. Reddy's Laboratories Ltd Major Business
9.10.3 Dr. Reddy's Laboratories Ltd Extended Oral Antibiotics Product and Services
9.10.4 Dr. Reddy's Laboratories Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Dr. Reddy's Laboratories Ltd Recent Developments/Updates
9.10.6 Dr. Reddy's Laboratories Ltd Competitive Strengths & Weaknesses
9.11 Cipla Ltd
9.11.1 Cipla Ltd Details
9.11.2 Cipla Ltd Major Business
9.11.3 Cipla Ltd Extended Oral Antibiotics Product and Services
9.11.4 Cipla Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Cipla Ltd Recent Developments/Updates
9.11.6 Cipla Ltd Competitive Strengths & Weaknesses
9.12 Lupin Ltd
9.12.1 Lupin Ltd Details
9.12.2 Lupin Ltd Major Business
9.12.3 Lupin Ltd Extended Oral Antibiotics Product and Services
9.12.4 Lupin Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Lupin Ltd Recent Developments/Updates
9.12.6 Lupin Ltd Competitive Strengths & Weaknesses
9.13 Zhejiang Hisun Pharmaceutical Co., Ltd
9.13.1 Zhejiang Hisun Pharmaceutical Co., Ltd Details
9.13.2 Zhejiang Hisun Pharmaceutical Co., Ltd Major Business
9.13.3 Zhejiang Hisun Pharmaceutical Co., Ltd Extended Oral Antibiotics Product and Services
9.13.4 Zhejiang Hisun Pharmaceutical Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
9.13.6 Zhejiang Hisun Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
9.14 Takeda Pharmaceutical Company Ltd
9.14.1 Takeda Pharmaceutical Company Ltd Details
9.14.2 Takeda Pharmaceutical Company Ltd Major Business
9.14.3 Takeda Pharmaceutical Company Ltd Extended Oral Antibiotics Product and Services
9.14.4 Takeda Pharmaceutical Company Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Takeda Pharmaceutical Company Ltd Recent Developments/Updates
9.14.6 Takeda Pharmaceutical Company Ltd Competitive Strengths & Weaknesses
9.15 Daiichi Sankyo Company Ltd
9.15.1 Daiichi Sankyo Company Ltd Details
9.15.2 Daiichi Sankyo Company Ltd Major Business
9.15.3 Daiichi Sankyo Company Ltd Extended Oral Antibiotics Product and Services
9.15.4 Daiichi Sankyo Company Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Daiichi Sankyo Company Ltd Recent Developments/Updates
9.15.6 Daiichi Sankyo Company Ltd Competitive Strengths & Weaknesses
9.16 Meiji Seika Pharma Co., Ltd
9.16.1 Meiji Seika Pharma Co., Ltd Details
9.16.2 Meiji Seika Pharma Co., Ltd Major Business
9.16.3 Meiji Seika Pharma Co., Ltd Extended Oral Antibiotics Product and Services
9.16.4 Meiji Seika Pharma Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Meiji Seika Pharma Co., Ltd Recent Developments/Updates
9.16.6 Meiji Seika Pharma Co., Ltd Competitive Strengths & Weaknesses
9.17 Boryung Co., Ltd
9.17.1 Boryung Co., Ltd Details
9.17.2 Boryung Co., Ltd Major Business
9.17.3 Boryung Co., Ltd Extended Oral Antibiotics Product and Services
9.17.4 Boryung Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Boryung Co., Ltd Recent Developments/Updates
9.17.6 Boryung Co., Ltd Competitive Strengths & Weaknesses
9.18 Orchid Pharma Ltd
9.18.1 Orchid Pharma Ltd Details
9.18.2 Orchid Pharma Ltd Major Business
9.18.3 Orchid Pharma Ltd Extended Oral Antibiotics Product and Services
9.18.4 Orchid Pharma Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Orchid Pharma Ltd Recent Developments/Updates
9.18.6 Orchid Pharma Ltd Competitive Strengths & Weaknesses
9.19 CSPC Pharmaceutical Group Ltd
9.19.1 CSPC Pharmaceutical Group Ltd Details
9.19.2 CSPC Pharmaceutical Group Ltd Major Business
9.19.3 CSPC Pharmaceutical Group Ltd Extended Oral Antibiotics Product and Services
9.19.4 CSPC Pharmaceutical Group Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 CSPC Pharmaceutical Group Ltd Recent Developments/Updates
9.19.6 CSPC Pharmaceutical Group Ltd Competitive Strengths & Weaknesses
9.20 Aspen Pharmacare Holdings Ltd
9.20.1 Aspen Pharmacare Holdings Ltd Details
9.20.2 Aspen Pharmacare Holdings Ltd Major Business
9.20.3 Aspen Pharmacare Holdings Ltd Extended Oral Antibiotics Product and Services
9.20.4 Aspen Pharmacare Holdings Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.20.5 Aspen Pharmacare Holdings Ltd Recent Developments/Updates
9.20.6 Aspen Pharmacare Holdings Ltd Competitive Strengths & Weaknesses
9.21 North China Pharmaceutical Group Corp
9.21.1 North China Pharmaceutical Group Corp Details
9.21.2 North China Pharmaceutical Group Corp Major Business
9.21.3 North China Pharmaceutical Group Corp Extended Oral Antibiotics Product and Services
9.21.4 North China Pharmaceutical Group Corp Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.21.5 North China Pharmaceutical Group Corp Recent Developments/Updates
9.21.6 North China Pharmaceutical Group Corp Competitive Strengths & Weaknesses
9.22 Shandong Lukang Pharmaceutical Co., Ltd
9.22.1 Shandong Lukang Pharmaceutical Co., Ltd Details
9.22.2 Shandong Lukang Pharmaceutical Co., Ltd Major Business
9.22.3 Shandong Lukang Pharmaceutical Co., Ltd Extended Oral Antibiotics Product and Services
9.22.4 Shandong Lukang Pharmaceutical Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.22.5 Shandong Lukang Pharmaceutical Co., Ltd Recent Developments/Updates
9.22.6 Shandong Lukang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
9.23 Zentiva
9.23.1 Zentiva Details
9.23.2 Zentiva Major Business
9.23.3 Zentiva Extended Oral Antibiotics Product and Services
9.23.4 Zentiva Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.23.5 Zentiva Recent Developments/Updates
9.23.6 Zentiva Competitive Strengths & Weaknesses
9.24 RedHill Biopharma Ltd
9.24.1 RedHill Biopharma Ltd Details
9.24.2 RedHill Biopharma Ltd Major Business
9.24.3 RedHill Biopharma Ltd Extended Oral Antibiotics Product and Services
9.24.4 RedHill Biopharma Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.24.5 RedHill Biopharma Ltd Recent Developments/Updates
9.24.6 RedHill Biopharma Ltd Competitive Strengths & Weaknesses
9.25 TaiGen Biotechnology Co., Ltd
9.25.1 TaiGen Biotechnology Co., Ltd Details
9.25.2 TaiGen Biotechnology Co., Ltd Major Business
9.25.3 TaiGen Biotechnology Co., Ltd Extended Oral Antibiotics Product and Services
9.25.4 TaiGen Biotechnology Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.25.5 TaiGen Biotechnology Co., Ltd Recent Developments/Updates
9.25.6 TaiGen Biotechnology Co., Ltd Competitive Strengths & Weaknesses
9.26 Taiwan Biotech Co., Ltd
9.26.1 Taiwan Biotech Co., Ltd Details
9.26.2 Taiwan Biotech Co., Ltd Major Business
9.26.3 Taiwan Biotech Co., Ltd Extended Oral Antibiotics Product and Services
9.26.4 Taiwan Biotech Co., Ltd Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.26.5 Taiwan Biotech Co., Ltd Recent Developments/Updates
9.26.6 Taiwan Biotech Co., Ltd Competitive Strengths & Weaknesses
9.27 Centrient Pharmaceuticals
9.27.1 Centrient Pharmaceuticals Details
9.27.2 Centrient Pharmaceuticals Major Business
9.27.3 Centrient Pharmaceuticals Extended Oral Antibiotics Product and Services
9.27.4 Centrient Pharmaceuticals Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.27.5 Centrient Pharmaceuticals Recent Developments/Updates
9.27.6 Centrient Pharmaceuticals Competitive Strengths & Weaknesses
9.28 Nabriva Therapeutics plc
9.28.1 Nabriva Therapeutics plc Details
9.28.2 Nabriva Therapeutics plc Major Business
9.28.3 Nabriva Therapeutics plc Extended Oral Antibiotics Product and Services
9.28.4 Nabriva Therapeutics plc Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.28.5 Nabriva Therapeutics plc Recent Developments/Updates
9.28.6 Nabriva Therapeutics plc Competitive Strengths & Weaknesses
9.29 Melinta Therapeutics Inc.
9.29.1 Melinta Therapeutics Inc. Details
9.29.2 Melinta Therapeutics Inc. Major Business
9.29.3 Melinta Therapeutics Inc. Extended Oral Antibiotics Product and Services
9.29.4 Melinta Therapeutics Inc. Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.29.5 Melinta Therapeutics Inc. Recent Developments/Updates
9.29.6 Melinta Therapeutics Inc. Competitive Strengths & Weaknesses
9.30 Lonza Group
9.30.1 Lonza Group Details
9.30.2 Lonza Group Major Business
9.30.3 Lonza Group Extended Oral Antibiotics Product and Services
9.30.4 Lonza Group Extended Oral Antibiotics Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.30.5 Lonza Group Recent Developments/Updates
9.30.6 Lonza Group Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Extended Oral Antibiotics Industry Chain
10.2 Extended Oral Antibiotics Upstream Analysis
10.2.1 Extended Oral Antibiotics Core Raw Materials
10.2.2 Main Manufacturers of Extended Oral Antibiotics Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Extended Oral Antibiotics Production Mode
10.6 Extended Oral Antibiotics Procurement Model
10.7 Extended Oral Antibiotics Industry Sales Model and Sales Channels
10.7.1 Extended Oral Antibiotics Sales Model
10.7.2 Extended Oral Antibiotics Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Extended Oral Antibiotics Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Extended Oral Antibiotics Production Value by Region (2021-2026) & (USD Million)
Table 3. World Extended Oral Antibiotics Production Value by Region (2027-2032) & (USD Million)
Table 4. World Extended Oral Antibiotics Production Value Market Share by Region (2021-2026)
Table 5. World Extended Oral Antibiotics Production Value Market Share by Region (2027-2032)
Table 6. World Extended Oral Antibiotics Production by Region (2021-2026) & (K Units)
Table 7. World Extended Oral Antibiotics Production by Region (2027-2032) & (K Units)
Table 8. World Extended Oral Antibiotics Production Market Share by Region (2021-2026)
Table 9. World Extended Oral Antibiotics Production Market Share by Region (2027-2032)
Table 10. World Extended Oral Antibiotics Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Extended Oral Antibiotics Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Extended Oral Antibiotics Major Market Trends
Table 13. World Extended Oral Antibiotics Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Extended Oral Antibiotics Consumption by Region (2021-2026) & (K Units)
Table 15. World Extended Oral Antibiotics Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Extended Oral Antibiotics Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Extended Oral Antibiotics Producers in 2025
Table 18. World Extended Oral Antibiotics Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Extended Oral Antibiotics Producers in 2025
Table 20. World Extended Oral Antibiotics Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Extended Oral Antibiotics Company Evaluation Quadrant
Table 22. World Extended Oral Antibiotics Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Extended Oral Antibiotics Production Site of Key Manufacturer
Table 24. Extended Oral Antibiotics Market: Company Product Type Footprint
Table 25. Extended Oral Antibiotics Market: Company Product Application Footprint
Table 26. Extended Oral Antibiotics Competitive Factors
Table 27. Extended Oral Antibiotics New Entrant and Capacity Expansion Plans
Table 28. Extended Oral Antibiotics Mergers & Acquisitions Activity
Table 29. United States VS China Extended Oral Antibiotics Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Extended Oral Antibiotics Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Extended Oral Antibiotics Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Extended Oral Antibiotics Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Extended Oral Antibiotics Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Extended Oral Antibiotics Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Extended Oral Antibiotics Production Market Share (2021-2026)
Table 37. China Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Extended Oral Antibiotics Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Extended Oral Antibiotics Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Extended Oral Antibiotics Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Extended Oral Antibiotics Production Market Share (2021-2026)
Table 42. Rest of World Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Extended Oral Antibiotics Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Extended Oral Antibiotics Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Extended Oral Antibiotics Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Extended Oral Antibiotics Production Market Share (2021-2026)
Table 47. World Extended Oral Antibiotics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Extended Oral Antibiotics Production by Type (2021-2026) & (K Units)
Table 49. World Extended Oral Antibiotics Production by Type (2027-2032) & (K Units)
Table 50. World Extended Oral Antibiotics Production Value by Type (2021-2026) & (USD Million)
Table 51. World Extended Oral Antibiotics Production Value by Type (2027-2032) & (USD Million)
Table 52. World Extended Oral Antibiotics Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Extended Oral Antibiotics Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Extended Oral Antibiotics Production Value by Antibiotic Spectrum, (USD Million), 2021 & 2025 & 2032
Table 55. World Extended Oral Antibiotics Production by Antibiotic Spectrum (2021-2026) & (K Units)
Table 56. World Extended Oral Antibiotics Production by Antibiotic Spectrum (2027-2032) & (K Units)
Table 57. World Extended Oral Antibiotics Production Value by Antibiotic Spectrum (2021-2026) & (USD Million)
Table 58. World Extended Oral Antibiotics Production Value by Antibiotic Spectrum (2027-2032) & (USD Million)
Table 59. World Extended Oral Antibiotics Average Price by Antibiotic Spectrum (2021-2026) & (US$/Unit)
Table 60. World Extended Oral Antibiotics Average Price by Antibiotic Spectrum (2027-2032) & (US$/Unit)
Table 61. World Extended Oral Antibiotics Production Value by Treatment Duration, (USD Million), 2021 & 2025 & 2032
Table 62. World Extended Oral Antibiotics Production by Treatment Duration (2021-2026) & (K Units)
Table 63. World Extended Oral Antibiotics Production by Treatment Duration (2027-2032) & (K Units)
Table 64. World Extended Oral Antibiotics Production Value by Treatment Duration (2021-2026) & (USD Million)
Table 65. World Extended Oral Antibiotics Production Value by Treatment Duration (2027-2032) & (USD Million)
Table 66. World Extended Oral Antibiotics Average Price by Treatment Duration (2021-2026) & (US$/Unit)
Table 67. World Extended Oral Antibiotics Average Price by Treatment Duration (2027-2032) & (US$/Unit)
Table 68. World Extended Oral Antibiotics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Extended Oral Antibiotics Production by Application (2021-2026) & (K Units)
Table 70. World Extended Oral Antibiotics Production by Application (2027-2032) & (K Units)
Table 71. World Extended Oral Antibiotics Production Value by Application (2021-2026) & (USD Million)
Table 72. World Extended Oral Antibiotics Production Value by Application (2027-2032) & (USD Million)
Table 73. World Extended Oral Antibiotics Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Extended Oral Antibiotics Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer Inc. Major Business
Table 77. Pfizer Inc. Extended Oral Antibiotics Product and Services
Table 78. Pfizer Inc. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer Inc. Recent Developments/Updates
Table 80. Pfizer Inc. Competitive Strengths & Weaknesses
Table 81. GSK plc. Basic Information, Manufacturing Base and Competitors
Table 82. GSK plc. Major Business
Table 83. GSK plc. Extended Oral Antibiotics Product and Services
Table 84. GSK plc. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK plc. Recent Developments/Updates
Table 86. GSK plc. Competitive Strengths & Weaknesses
Table 87. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 88. Merck & Co., Inc. Major Business
Table 89. Merck & Co., Inc. Extended Oral Antibiotics Product and Services
Table 90. Merck & Co., Inc. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Merck & Co., Inc. Recent Developments/Updates
Table 92. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 93. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 94. Novartis AG Major Business
Table 95. Novartis AG Extended Oral Antibiotics Product and Services
Table 96. Novartis AG Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Novartis AG Recent Developments/Updates
Table 98. Novartis AG Competitive Strengths & Weaknesses
Table 99. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 100. Sanofi S.A. Major Business
Table 101. Sanofi S.A. Extended Oral Antibiotics Product and Services
Table 102. Sanofi S.A. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Sanofi S.A. Recent Developments/Updates
Table 104. Sanofi S.A. Competitive Strengths & Weaknesses
Table 105. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 106. Teva Pharmaceutical Industries Major Business
Table 107. Teva Pharmaceutical Industries Extended Oral Antibiotics Product and Services
Table 108. Teva Pharmaceutical Industries Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Teva Pharmaceutical Industries Recent Developments/Updates
Table 110. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 111. Viatris Inc. Basic Information, Manufacturing Base and Competitors
Table 112. Viatris Inc. Major Business
Table 113. Viatris Inc. Extended Oral Antibiotics Product and Services
Table 114. Viatris Inc. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Viatris Inc. Recent Developments/Updates
Table 116. Viatris Inc. Competitive Strengths & Weaknesses
Table 117. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 118. Aurobindo Pharma Ltd Major Business
Table 119. Aurobindo Pharma Ltd Extended Oral Antibiotics Product and Services
Table 120. Aurobindo Pharma Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Aurobindo Pharma Ltd Recent Developments/Updates
Table 122. Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
Table 123. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 124. Sun Pharmaceutical Industries Ltd Major Business
Table 125. Sun Pharmaceutical Industries Ltd Extended Oral Antibiotics Product and Services
Table 126. Sun Pharmaceutical Industries Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 128. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 129. Dr. Reddy's Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 130. Dr. Reddy's Laboratories Ltd Major Business
Table 131. Dr. Reddy's Laboratories Ltd Extended Oral Antibiotics Product and Services
Table 132. Dr. Reddy's Laboratories Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Dr. Reddy's Laboratories Ltd Recent Developments/Updates
Table 134. Dr. Reddy's Laboratories Ltd Competitive Strengths & Weaknesses
Table 135. Cipla Ltd Basic Information, Manufacturing Base and Competitors
Table 136. Cipla Ltd Major Business
Table 137. Cipla Ltd Extended Oral Antibiotics Product and Services
Table 138. Cipla Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Cipla Ltd Recent Developments/Updates
Table 140. Cipla Ltd Competitive Strengths & Weaknesses
Table 141. Lupin Ltd Basic Information, Manufacturing Base and Competitors
Table 142. Lupin Ltd Major Business
Table 143. Lupin Ltd Extended Oral Antibiotics Product and Services
Table 144. Lupin Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Lupin Ltd Recent Developments/Updates
Table 146. Lupin Ltd Competitive Strengths & Weaknesses
Table 147. Zhejiang Hisun Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 148. Zhejiang Hisun Pharmaceutical Co., Ltd Major Business
Table 149. Zhejiang Hisun Pharmaceutical Co., Ltd Extended Oral Antibiotics Product and Services
Table 150. Zhejiang Hisun Pharmaceutical Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
Table 152. Zhejiang Hisun Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 153. Takeda Pharmaceutical Company Ltd Basic Information, Manufacturing Base and Competitors
Table 154. Takeda Pharmaceutical Company Ltd Major Business
Table 155. Takeda Pharmaceutical Company Ltd Extended Oral Antibiotics Product and Services
Table 156. Takeda Pharmaceutical Company Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Takeda Pharmaceutical Company Ltd Recent Developments/Updates
Table 158. Takeda Pharmaceutical Company Ltd Competitive Strengths & Weaknesses
Table 159. Daiichi Sankyo Company Ltd Basic Information, Manufacturing Base and Competitors
Table 160. Daiichi Sankyo Company Ltd Major Business
Table 161. Daiichi Sankyo Company Ltd Extended Oral Antibiotics Product and Services
Table 162. Daiichi Sankyo Company Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Daiichi Sankyo Company Ltd Recent Developments/Updates
Table 164. Daiichi Sankyo Company Ltd Competitive Strengths & Weaknesses
Table 165. Meiji Seika Pharma Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 166. Meiji Seika Pharma Co., Ltd Major Business
Table 167. Meiji Seika Pharma Co., Ltd Extended Oral Antibiotics Product and Services
Table 168. Meiji Seika Pharma Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Meiji Seika Pharma Co., Ltd Recent Developments/Updates
Table 170. Meiji Seika Pharma Co., Ltd Competitive Strengths & Weaknesses
Table 171. Boryung Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 172. Boryung Co., Ltd Major Business
Table 173. Boryung Co., Ltd Extended Oral Antibiotics Product and Services
Table 174. Boryung Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Boryung Co., Ltd Recent Developments/Updates
Table 176. Boryung Co., Ltd Competitive Strengths & Weaknesses
Table 177. Orchid Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 178. Orchid Pharma Ltd Major Business
Table 179. Orchid Pharma Ltd Extended Oral Antibiotics Product and Services
Table 180. Orchid Pharma Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Orchid Pharma Ltd Recent Developments/Updates
Table 182. Orchid Pharma Ltd Competitive Strengths & Weaknesses
Table 183. CSPC Pharmaceutical Group Ltd Basic Information, Manufacturing Base and Competitors
Table 184. CSPC Pharmaceutical Group Ltd Major Business
Table 185. CSPC Pharmaceutical Group Ltd Extended Oral Antibiotics Product and Services
Table 186. CSPC Pharmaceutical Group Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. CSPC Pharmaceutical Group Ltd Recent Developments/Updates
Table 188. CSPC Pharmaceutical Group Ltd Competitive Strengths & Weaknesses
Table 189. Aspen Pharmacare Holdings Ltd Basic Information, Manufacturing Base and Competitors
Table 190. Aspen Pharmacare Holdings Ltd Major Business
Table 191. Aspen Pharmacare Holdings Ltd Extended Oral Antibiotics Product and Services
Table 192. Aspen Pharmacare Holdings Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Aspen Pharmacare Holdings Ltd Recent Developments/Updates
Table 194. Aspen Pharmacare Holdings Ltd Competitive Strengths & Weaknesses
Table 195. North China Pharmaceutical Group Corp Basic Information, Manufacturing Base and Competitors
Table 196. North China Pharmaceutical Group Corp Major Business
Table 197. North China Pharmaceutical Group Corp Extended Oral Antibiotics Product and Services
Table 198. North China Pharmaceutical Group Corp Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. North China Pharmaceutical Group Corp Recent Developments/Updates
Table 200. North China Pharmaceutical Group Corp Competitive Strengths & Weaknesses
Table 201. Shandong Lukang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 202. Shandong Lukang Pharmaceutical Co., Ltd Major Business
Table 203. Shandong Lukang Pharmaceutical Co., Ltd Extended Oral Antibiotics Product and Services
Table 204. Shandong Lukang Pharmaceutical Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Shandong Lukang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 206. Shandong Lukang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 207. Zentiva Basic Information, Manufacturing Base and Competitors
Table 208. Zentiva Major Business
Table 209. Zentiva Extended Oral Antibiotics Product and Services
Table 210. Zentiva Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Zentiva Recent Developments/Updates
Table 212. Zentiva Competitive Strengths & Weaknesses
Table 213. RedHill Biopharma Ltd Basic Information, Manufacturing Base and Competitors
Table 214. RedHill Biopharma Ltd Major Business
Table 215. RedHill Biopharma Ltd Extended Oral Antibiotics Product and Services
Table 216. RedHill Biopharma Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. RedHill Biopharma Ltd Recent Developments/Updates
Table 218. RedHill Biopharma Ltd Competitive Strengths & Weaknesses
Table 219. TaiGen Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 220. TaiGen Biotechnology Co., Ltd Major Business
Table 221. TaiGen Biotechnology Co., Ltd Extended Oral Antibiotics Product and Services
Table 222. TaiGen Biotechnology Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. TaiGen Biotechnology Co., Ltd Recent Developments/Updates
Table 224. TaiGen Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 225. Taiwan Biotech Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 226. Taiwan Biotech Co., Ltd Major Business
Table 227. Taiwan Biotech Co., Ltd Extended Oral Antibiotics Product and Services
Table 228. Taiwan Biotech Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Taiwan Biotech Co., Ltd Recent Developments/Updates
Table 230. Taiwan Biotech Co., Ltd Competitive Strengths & Weaknesses
Table 231. Centrient Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 232. Centrient Pharmaceuticals Major Business
Table 233. Centrient Pharmaceuticals Extended Oral Antibiotics Product and Services
Table 234. Centrient Pharmaceuticals Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Centrient Pharmaceuticals Recent Developments/Updates
Table 236. Centrient Pharmaceuticals Competitive Strengths & Weaknesses
Table 237. Nabriva Therapeutics plc Basic Information, Manufacturing Base and Competitors
Table 238. Nabriva Therapeutics plc Major Business
Table 239. Nabriva Therapeutics plc Extended Oral Antibiotics Product and Services
Table 240. Nabriva Therapeutics plc Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 241. Nabriva Therapeutics plc Recent Developments/Updates
Table 242. Nabriva Therapeutics plc Competitive Strengths & Weaknesses
Table 243. Melinta Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 244. Melinta Therapeutics Inc. Major Business
Table 245. Melinta Therapeutics Inc. Extended Oral Antibiotics Product and Services
Table 246. Melinta Therapeutics Inc. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 247. Melinta Therapeutics Inc. Recent Developments/Updates
Table 248. Melinta Therapeutics Inc. Competitive Strengths & Weaknesses
Table 249. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 250. Lonza Group Major Business
Table 251. Lonza Group Extended Oral Antibiotics Product and Services
Table 252. Lonza Group Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 253. Lonza Group Recent Developments/Updates
Table 254. Lonza Group Competitive Strengths & Weaknesses
Table 255. Global Key Players of Extended Oral Antibiotics Upstream (Raw Materials)
Table 256. Global Extended Oral Antibiotics Typical Customers
Table 257. Extended Oral Antibiotics Typical Distributors
Table 1. World Extended Oral Antibiotics Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Extended Oral Antibiotics Production Value by Region (2021-2026) & (USD Million)
Table 3. World Extended Oral Antibiotics Production Value by Region (2027-2032) & (USD Million)
Table 4. World Extended Oral Antibiotics Production Value Market Share by Region (2021-2026)
Table 5. World Extended Oral Antibiotics Production Value Market Share by Region (2027-2032)
Table 6. World Extended Oral Antibiotics Production by Region (2021-2026) & (K Units)
Table 7. World Extended Oral Antibiotics Production by Region (2027-2032) & (K Units)
Table 8. World Extended Oral Antibiotics Production Market Share by Region (2021-2026)
Table 9. World Extended Oral Antibiotics Production Market Share by Region (2027-2032)
Table 10. World Extended Oral Antibiotics Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Extended Oral Antibiotics Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Extended Oral Antibiotics Major Market Trends
Table 13. World Extended Oral Antibiotics Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Extended Oral Antibiotics Consumption by Region (2021-2026) & (K Units)
Table 15. World Extended Oral Antibiotics Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Extended Oral Antibiotics Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Extended Oral Antibiotics Producers in 2025
Table 18. World Extended Oral Antibiotics Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Extended Oral Antibiotics Producers in 2025
Table 20. World Extended Oral Antibiotics Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Extended Oral Antibiotics Company Evaluation Quadrant
Table 22. World Extended Oral Antibiotics Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Extended Oral Antibiotics Production Site of Key Manufacturer
Table 24. Extended Oral Antibiotics Market: Company Product Type Footprint
Table 25. Extended Oral Antibiotics Market: Company Product Application Footprint
Table 26. Extended Oral Antibiotics Competitive Factors
Table 27. Extended Oral Antibiotics New Entrant and Capacity Expansion Plans
Table 28. Extended Oral Antibiotics Mergers & Acquisitions Activity
Table 29. United States VS China Extended Oral Antibiotics Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Extended Oral Antibiotics Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Extended Oral Antibiotics Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Extended Oral Antibiotics Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Extended Oral Antibiotics Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Extended Oral Antibiotics Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Extended Oral Antibiotics Production Market Share (2021-2026)
Table 37. China Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Extended Oral Antibiotics Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Extended Oral Antibiotics Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Extended Oral Antibiotics Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Extended Oral Antibiotics Production Market Share (2021-2026)
Table 42. Rest of World Based Extended Oral Antibiotics Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Extended Oral Antibiotics Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Extended Oral Antibiotics Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Extended Oral Antibiotics Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Extended Oral Antibiotics Production Market Share (2021-2026)
Table 47. World Extended Oral Antibiotics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Extended Oral Antibiotics Production by Type (2021-2026) & (K Units)
Table 49. World Extended Oral Antibiotics Production by Type (2027-2032) & (K Units)
Table 50. World Extended Oral Antibiotics Production Value by Type (2021-2026) & (USD Million)
Table 51. World Extended Oral Antibiotics Production Value by Type (2027-2032) & (USD Million)
Table 52. World Extended Oral Antibiotics Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Extended Oral Antibiotics Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Extended Oral Antibiotics Production Value by Antibiotic Spectrum, (USD Million), 2021 & 2025 & 2032
Table 55. World Extended Oral Antibiotics Production by Antibiotic Spectrum (2021-2026) & (K Units)
Table 56. World Extended Oral Antibiotics Production by Antibiotic Spectrum (2027-2032) & (K Units)
Table 57. World Extended Oral Antibiotics Production Value by Antibiotic Spectrum (2021-2026) & (USD Million)
Table 58. World Extended Oral Antibiotics Production Value by Antibiotic Spectrum (2027-2032) & (USD Million)
Table 59. World Extended Oral Antibiotics Average Price by Antibiotic Spectrum (2021-2026) & (US$/Unit)
Table 60. World Extended Oral Antibiotics Average Price by Antibiotic Spectrum (2027-2032) & (US$/Unit)
Table 61. World Extended Oral Antibiotics Production Value by Treatment Duration, (USD Million), 2021 & 2025 & 2032
Table 62. World Extended Oral Antibiotics Production by Treatment Duration (2021-2026) & (K Units)
Table 63. World Extended Oral Antibiotics Production by Treatment Duration (2027-2032) & (K Units)
Table 64. World Extended Oral Antibiotics Production Value by Treatment Duration (2021-2026) & (USD Million)
Table 65. World Extended Oral Antibiotics Production Value by Treatment Duration (2027-2032) & (USD Million)
Table 66. World Extended Oral Antibiotics Average Price by Treatment Duration (2021-2026) & (US$/Unit)
Table 67. World Extended Oral Antibiotics Average Price by Treatment Duration (2027-2032) & (US$/Unit)
Table 68. World Extended Oral Antibiotics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Extended Oral Antibiotics Production by Application (2021-2026) & (K Units)
Table 70. World Extended Oral Antibiotics Production by Application (2027-2032) & (K Units)
Table 71. World Extended Oral Antibiotics Production Value by Application (2021-2026) & (USD Million)
Table 72. World Extended Oral Antibiotics Production Value by Application (2027-2032) & (USD Million)
Table 73. World Extended Oral Antibiotics Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Extended Oral Antibiotics Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer Inc. Major Business
Table 77. Pfizer Inc. Extended Oral Antibiotics Product and Services
Table 78. Pfizer Inc. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer Inc. Recent Developments/Updates
Table 80. Pfizer Inc. Competitive Strengths & Weaknesses
Table 81. GSK plc. Basic Information, Manufacturing Base and Competitors
Table 82. GSK plc. Major Business
Table 83. GSK plc. Extended Oral Antibiotics Product and Services
Table 84. GSK plc. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. GSK plc. Recent Developments/Updates
Table 86. GSK plc. Competitive Strengths & Weaknesses
Table 87. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 88. Merck & Co., Inc. Major Business
Table 89. Merck & Co., Inc. Extended Oral Antibiotics Product and Services
Table 90. Merck & Co., Inc. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Merck & Co., Inc. Recent Developments/Updates
Table 92. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 93. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 94. Novartis AG Major Business
Table 95. Novartis AG Extended Oral Antibiotics Product and Services
Table 96. Novartis AG Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Novartis AG Recent Developments/Updates
Table 98. Novartis AG Competitive Strengths & Weaknesses
Table 99. Sanofi S.A. Basic Information, Manufacturing Base and Competitors
Table 100. Sanofi S.A. Major Business
Table 101. Sanofi S.A. Extended Oral Antibiotics Product and Services
Table 102. Sanofi S.A. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Sanofi S.A. Recent Developments/Updates
Table 104. Sanofi S.A. Competitive Strengths & Weaknesses
Table 105. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 106. Teva Pharmaceutical Industries Major Business
Table 107. Teva Pharmaceutical Industries Extended Oral Antibiotics Product and Services
Table 108. Teva Pharmaceutical Industries Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Teva Pharmaceutical Industries Recent Developments/Updates
Table 110. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 111. Viatris Inc. Basic Information, Manufacturing Base and Competitors
Table 112. Viatris Inc. Major Business
Table 113. Viatris Inc. Extended Oral Antibiotics Product and Services
Table 114. Viatris Inc. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Viatris Inc. Recent Developments/Updates
Table 116. Viatris Inc. Competitive Strengths & Weaknesses
Table 117. Aurobindo Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 118. Aurobindo Pharma Ltd Major Business
Table 119. Aurobindo Pharma Ltd Extended Oral Antibiotics Product and Services
Table 120. Aurobindo Pharma Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Aurobindo Pharma Ltd Recent Developments/Updates
Table 122. Aurobindo Pharma Ltd Competitive Strengths & Weaknesses
Table 123. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 124. Sun Pharmaceutical Industries Ltd Major Business
Table 125. Sun Pharmaceutical Industries Ltd Extended Oral Antibiotics Product and Services
Table 126. Sun Pharmaceutical Industries Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 128. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 129. Dr. Reddy's Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 130. Dr. Reddy's Laboratories Ltd Major Business
Table 131. Dr. Reddy's Laboratories Ltd Extended Oral Antibiotics Product and Services
Table 132. Dr. Reddy's Laboratories Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Dr. Reddy's Laboratories Ltd Recent Developments/Updates
Table 134. Dr. Reddy's Laboratories Ltd Competitive Strengths & Weaknesses
Table 135. Cipla Ltd Basic Information, Manufacturing Base and Competitors
Table 136. Cipla Ltd Major Business
Table 137. Cipla Ltd Extended Oral Antibiotics Product and Services
Table 138. Cipla Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Cipla Ltd Recent Developments/Updates
Table 140. Cipla Ltd Competitive Strengths & Weaknesses
Table 141. Lupin Ltd Basic Information, Manufacturing Base and Competitors
Table 142. Lupin Ltd Major Business
Table 143. Lupin Ltd Extended Oral Antibiotics Product and Services
Table 144. Lupin Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Lupin Ltd Recent Developments/Updates
Table 146. Lupin Ltd Competitive Strengths & Weaknesses
Table 147. Zhejiang Hisun Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 148. Zhejiang Hisun Pharmaceutical Co., Ltd Major Business
Table 149. Zhejiang Hisun Pharmaceutical Co., Ltd Extended Oral Antibiotics Product and Services
Table 150. Zhejiang Hisun Pharmaceutical Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Zhejiang Hisun Pharmaceutical Co., Ltd Recent Developments/Updates
Table 152. Zhejiang Hisun Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 153. Takeda Pharmaceutical Company Ltd Basic Information, Manufacturing Base and Competitors
Table 154. Takeda Pharmaceutical Company Ltd Major Business
Table 155. Takeda Pharmaceutical Company Ltd Extended Oral Antibiotics Product and Services
Table 156. Takeda Pharmaceutical Company Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Takeda Pharmaceutical Company Ltd Recent Developments/Updates
Table 158. Takeda Pharmaceutical Company Ltd Competitive Strengths & Weaknesses
Table 159. Daiichi Sankyo Company Ltd Basic Information, Manufacturing Base and Competitors
Table 160. Daiichi Sankyo Company Ltd Major Business
Table 161. Daiichi Sankyo Company Ltd Extended Oral Antibiotics Product and Services
Table 162. Daiichi Sankyo Company Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Daiichi Sankyo Company Ltd Recent Developments/Updates
Table 164. Daiichi Sankyo Company Ltd Competitive Strengths & Weaknesses
Table 165. Meiji Seika Pharma Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 166. Meiji Seika Pharma Co., Ltd Major Business
Table 167. Meiji Seika Pharma Co., Ltd Extended Oral Antibiotics Product and Services
Table 168. Meiji Seika Pharma Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Meiji Seika Pharma Co., Ltd Recent Developments/Updates
Table 170. Meiji Seika Pharma Co., Ltd Competitive Strengths & Weaknesses
Table 171. Boryung Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 172. Boryung Co., Ltd Major Business
Table 173. Boryung Co., Ltd Extended Oral Antibiotics Product and Services
Table 174. Boryung Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Boryung Co., Ltd Recent Developments/Updates
Table 176. Boryung Co., Ltd Competitive Strengths & Weaknesses
Table 177. Orchid Pharma Ltd Basic Information, Manufacturing Base and Competitors
Table 178. Orchid Pharma Ltd Major Business
Table 179. Orchid Pharma Ltd Extended Oral Antibiotics Product and Services
Table 180. Orchid Pharma Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Orchid Pharma Ltd Recent Developments/Updates
Table 182. Orchid Pharma Ltd Competitive Strengths & Weaknesses
Table 183. CSPC Pharmaceutical Group Ltd Basic Information, Manufacturing Base and Competitors
Table 184. CSPC Pharmaceutical Group Ltd Major Business
Table 185. CSPC Pharmaceutical Group Ltd Extended Oral Antibiotics Product and Services
Table 186. CSPC Pharmaceutical Group Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. CSPC Pharmaceutical Group Ltd Recent Developments/Updates
Table 188. CSPC Pharmaceutical Group Ltd Competitive Strengths & Weaknesses
Table 189. Aspen Pharmacare Holdings Ltd Basic Information, Manufacturing Base and Competitors
Table 190. Aspen Pharmacare Holdings Ltd Major Business
Table 191. Aspen Pharmacare Holdings Ltd Extended Oral Antibiotics Product and Services
Table 192. Aspen Pharmacare Holdings Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 193. Aspen Pharmacare Holdings Ltd Recent Developments/Updates
Table 194. Aspen Pharmacare Holdings Ltd Competitive Strengths & Weaknesses
Table 195. North China Pharmaceutical Group Corp Basic Information, Manufacturing Base and Competitors
Table 196. North China Pharmaceutical Group Corp Major Business
Table 197. North China Pharmaceutical Group Corp Extended Oral Antibiotics Product and Services
Table 198. North China Pharmaceutical Group Corp Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 199. North China Pharmaceutical Group Corp Recent Developments/Updates
Table 200. North China Pharmaceutical Group Corp Competitive Strengths & Weaknesses
Table 201. Shandong Lukang Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 202. Shandong Lukang Pharmaceutical Co., Ltd Major Business
Table 203. Shandong Lukang Pharmaceutical Co., Ltd Extended Oral Antibiotics Product and Services
Table 204. Shandong Lukang Pharmaceutical Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 205. Shandong Lukang Pharmaceutical Co., Ltd Recent Developments/Updates
Table 206. Shandong Lukang Pharmaceutical Co., Ltd Competitive Strengths & Weaknesses
Table 207. Zentiva Basic Information, Manufacturing Base and Competitors
Table 208. Zentiva Major Business
Table 209. Zentiva Extended Oral Antibiotics Product and Services
Table 210. Zentiva Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 211. Zentiva Recent Developments/Updates
Table 212. Zentiva Competitive Strengths & Weaknesses
Table 213. RedHill Biopharma Ltd Basic Information, Manufacturing Base and Competitors
Table 214. RedHill Biopharma Ltd Major Business
Table 215. RedHill Biopharma Ltd Extended Oral Antibiotics Product and Services
Table 216. RedHill Biopharma Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 217. RedHill Biopharma Ltd Recent Developments/Updates
Table 218. RedHill Biopharma Ltd Competitive Strengths & Weaknesses
Table 219. TaiGen Biotechnology Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 220. TaiGen Biotechnology Co., Ltd Major Business
Table 221. TaiGen Biotechnology Co., Ltd Extended Oral Antibiotics Product and Services
Table 222. TaiGen Biotechnology Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 223. TaiGen Biotechnology Co., Ltd Recent Developments/Updates
Table 224. TaiGen Biotechnology Co., Ltd Competitive Strengths & Weaknesses
Table 225. Taiwan Biotech Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 226. Taiwan Biotech Co., Ltd Major Business
Table 227. Taiwan Biotech Co., Ltd Extended Oral Antibiotics Product and Services
Table 228. Taiwan Biotech Co., Ltd Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 229. Taiwan Biotech Co., Ltd Recent Developments/Updates
Table 230. Taiwan Biotech Co., Ltd Competitive Strengths & Weaknesses
Table 231. Centrient Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 232. Centrient Pharmaceuticals Major Business
Table 233. Centrient Pharmaceuticals Extended Oral Antibiotics Product and Services
Table 234. Centrient Pharmaceuticals Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 235. Centrient Pharmaceuticals Recent Developments/Updates
Table 236. Centrient Pharmaceuticals Competitive Strengths & Weaknesses
Table 237. Nabriva Therapeutics plc Basic Information, Manufacturing Base and Competitors
Table 238. Nabriva Therapeutics plc Major Business
Table 239. Nabriva Therapeutics plc Extended Oral Antibiotics Product and Services
Table 240. Nabriva Therapeutics plc Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 241. Nabriva Therapeutics plc Recent Developments/Updates
Table 242. Nabriva Therapeutics plc Competitive Strengths & Weaknesses
Table 243. Melinta Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 244. Melinta Therapeutics Inc. Major Business
Table 245. Melinta Therapeutics Inc. Extended Oral Antibiotics Product and Services
Table 246. Melinta Therapeutics Inc. Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 247. Melinta Therapeutics Inc. Recent Developments/Updates
Table 248. Melinta Therapeutics Inc. Competitive Strengths & Weaknesses
Table 249. Lonza Group Basic Information, Manufacturing Base and Competitors
Table 250. Lonza Group Major Business
Table 251. Lonza Group Extended Oral Antibiotics Product and Services
Table 252. Lonza Group Extended Oral Antibiotics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 253. Lonza Group Recent Developments/Updates
Table 254. Lonza Group Competitive Strengths & Weaknesses
Table 255. Global Key Players of Extended Oral Antibiotics Upstream (Raw Materials)
Table 256. Global Extended Oral Antibiotics Typical Customers
Table 257. Extended Oral Antibiotics Typical Distributors
LIST OF FIGURES
Figure 1. Extended Oral Antibiotics Picture
Figure 2. World Extended Oral Antibiotics Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Extended Oral Antibiotics Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 5. World Extended Oral Antibiotics Average Price (2021-2032) & (US$/Unit)
Figure 6. World Extended Oral Antibiotics Production Value Market Share by Region (2021-2032)
Figure 7. World Extended Oral Antibiotics Production Market Share by Region (2021-2032)
Figure 8. North America Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 9. Europe Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 10. China Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 11. Japan Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 12. India Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 13. Extended Oral Antibiotics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 16. World Extended Oral Antibiotics Consumption Market Share by Region (2021-2032)
Figure 17. United States Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 18. China Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 19. Europe Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 20. Japan Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 21. South Korea Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 22. ASEAN Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 23. India Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 24. Producer Shipments of Extended Oral Antibiotics by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Extended Oral Antibiotics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Extended Oral Antibiotics Markets in 2025
Figure 27. United States VS China: Extended Oral Antibiotics Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Extended Oral Antibiotics Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Extended Oral Antibiotics Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Extended Oral Antibiotics Production Market Share 2025
Figure 31. China Based Manufacturers Extended Oral Antibiotics Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Extended Oral Antibiotics Production Market Share 2025
Figure 33. World Extended Oral Antibiotics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Extended Oral Antibiotics Production Value Market Share by Type in 2025
Figure 35. Extended Release Oral Antibiotics
Figure 36. Oral Penicillin Derivatives
Figure 37. Oral Cephalosporins
Figure 38. Oral Macrolides
Figure 39. Others
Figure 40. World Extended Oral Antibiotics Production Market Share by Type (2021-2032)
Figure 41. World Extended Oral Antibiotics Production Value Market Share by Type (2021-2032)
Figure 42. World Extended Oral Antibiotics Average Price by Type (2021-2032) & (US$/Unit)
Figure 43. World Extended Oral Antibiotics Production Value by Antibiotic Spectrum, (USD Million), 2021 & 2025 & 2032
Figure 44. World Extended Oral Antibiotics Production Value Market Share by Antibiotic Spectrum in 2025
Figure 45. Narrow Spectrum Antibiotics
Figure 46. Broad Spectrum Antibiotics
Figure 47. World Extended Oral Antibiotics Production Market Share by Antibiotic Spectrum (2021-2032)
Figure 48. World Extended Oral Antibiotics Production Value Market Share by Antibiotic Spectrum (2021-2032)
Figure 49. World Extended Oral Antibiotics Average Price by Antibiotic Spectrum (2021-2032) & (US$/Unit)
Figure 50. World Extended Oral Antibiotics Production Value by Treatment Duration, (USD Million), 2021 & 2025 & 2032
Figure 51. World Extended Oral Antibiotics Production Value Market Share by Treatment Duration in 2025
Figure 52. Short Extended Course (7-10 Days)
Figure 53. Standard Extended Course (10-14 Days)
Figure 54. Prolonged Course (14-28 Days)
Figure 55. Long Term Suppression (>28 Days to Months)
Figure 56. Others
Figure 57. World Extended Oral Antibiotics Production Market Share by Treatment Duration (2021-2032)
Figure 58. World Extended Oral Antibiotics Production Value Market Share by Treatment Duration (2021-2032)
Figure 59. World Extended Oral Antibiotics Average Price by Treatment Duration (2021-2032) & (US$/Unit)
Figure 60. World Extended Oral Antibiotics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Extended Oral Antibiotics Production Value Market Share by Application in 2025
Figure 62. Hospitals
Figure 63. Clinics
Figure 64. Pharmacy
Figure 65. Others
Figure 66. World Extended Oral Antibiotics Production Market Share by Application (2021-2032)
Figure 67. World Extended Oral Antibiotics Production Value Market Share by Application (2021-2032)
Figure 68. World Extended Oral Antibiotics Average Price by Application (2021-2032) & (US$/Unit)
Figure 69. Extended Oral Antibiotics Industry Chain
Figure 70. Extended Oral Antibiotics Procurement Model
Figure 71. Extended Oral Antibiotics Sales Model
Figure 72. Extended Oral Antibiotics Sales Channels, Direct Sales, and Distribution
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Extended Oral Antibiotics Picture
Figure 2. World Extended Oral Antibiotics Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Extended Oral Antibiotics Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 5. World Extended Oral Antibiotics Average Price (2021-2032) & (US$/Unit)
Figure 6. World Extended Oral Antibiotics Production Value Market Share by Region (2021-2032)
Figure 7. World Extended Oral Antibiotics Production Market Share by Region (2021-2032)
Figure 8. North America Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 9. Europe Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 10. China Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 11. Japan Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 12. India Extended Oral Antibiotics Production (2021-2032) & (K Units)
Figure 13. Extended Oral Antibiotics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 16. World Extended Oral Antibiotics Consumption Market Share by Region (2021-2032)
Figure 17. United States Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 18. China Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 19. Europe Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 20. Japan Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 21. South Korea Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 22. ASEAN Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 23. India Extended Oral Antibiotics Consumption (2021-2032) & (K Units)
Figure 24. Producer Shipments of Extended Oral Antibiotics by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Extended Oral Antibiotics Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Extended Oral Antibiotics Markets in 2025
Figure 27. United States VS China: Extended Oral Antibiotics Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Extended Oral Antibiotics Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Extended Oral Antibiotics Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Extended Oral Antibiotics Production Market Share 2025
Figure 31. China Based Manufacturers Extended Oral Antibiotics Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Extended Oral Antibiotics Production Market Share 2025
Figure 33. World Extended Oral Antibiotics Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Extended Oral Antibiotics Production Value Market Share by Type in 2025
Figure 35. Extended Release Oral Antibiotics
Figure 36. Oral Penicillin Derivatives
Figure 37. Oral Cephalosporins
Figure 38. Oral Macrolides
Figure 39. Others
Figure 40. World Extended Oral Antibiotics Production Market Share by Type (2021-2032)
Figure 41. World Extended Oral Antibiotics Production Value Market Share by Type (2021-2032)
Figure 42. World Extended Oral Antibiotics Average Price by Type (2021-2032) & (US$/Unit)
Figure 43. World Extended Oral Antibiotics Production Value by Antibiotic Spectrum, (USD Million), 2021 & 2025 & 2032
Figure 44. World Extended Oral Antibiotics Production Value Market Share by Antibiotic Spectrum in 2025
Figure 45. Narrow Spectrum Antibiotics
Figure 46. Broad Spectrum Antibiotics
Figure 47. World Extended Oral Antibiotics Production Market Share by Antibiotic Spectrum (2021-2032)
Figure 48. World Extended Oral Antibiotics Production Value Market Share by Antibiotic Spectrum (2021-2032)
Figure 49. World Extended Oral Antibiotics Average Price by Antibiotic Spectrum (2021-2032) & (US$/Unit)
Figure 50. World Extended Oral Antibiotics Production Value by Treatment Duration, (USD Million), 2021 & 2025 & 2032
Figure 51. World Extended Oral Antibiotics Production Value Market Share by Treatment Duration in 2025
Figure 52. Short Extended Course (7-10 Days)
Figure 53. Standard Extended Course (10-14 Days)
Figure 54. Prolonged Course (14-28 Days)
Figure 55. Long Term Suppression (>28 Days to Months)
Figure 56. Others
Figure 57. World Extended Oral Antibiotics Production Market Share by Treatment Duration (2021-2032)
Figure 58. World Extended Oral Antibiotics Production Value Market Share by Treatment Duration (2021-2032)
Figure 59. World Extended Oral Antibiotics Average Price by Treatment Duration (2021-2032) & (US$/Unit)
Figure 60. World Extended Oral Antibiotics Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 61. World Extended Oral Antibiotics Production Value Market Share by Application in 2025
Figure 62. Hospitals
Figure 63. Clinics
Figure 64. Pharmacy
Figure 65. Others
Figure 66. World Extended Oral Antibiotics Production Market Share by Application (2021-2032)
Figure 67. World Extended Oral Antibiotics Production Value Market Share by Application (2021-2032)
Figure 68. World Extended Oral Antibiotics Average Price by Application (2021-2032) & (US$/Unit)
Figure 69. Extended Oral Antibiotics Industry Chain
Figure 70. Extended Oral Antibiotics Procurement Model
Figure 71. Extended Oral Antibiotics Sales Model
Figure 72. Extended Oral Antibiotics Sales Channels, Direct Sales, and Distribution
Figure 73. Methodology
Figure 74. Research Process and Data Source
